Seema Khan, MD

Bio

Dr. Seema Ahsan Khan, MD, is a surgical oncologist specializing in breast cancer treatment and prevention. A Professor of Surgery at the Feinberg School of Medicine at Northwestern University, she leads clinical and research efforts at the Lynn Sage Comprehensive Breast Center, focusing on high-risk patients and innovative surgical approaches. As principal investigator of the Northwestern Cancer Prevention Consortium, Dr. Khan advances early-phase trials in cancer prevention. Her research explores novel prevention therapies, transdermal drug delivery, and minimally invasive techniques for biomarker analysis.

Optimizing Family Planning for Young Women at High risk of Breast Cancer

Tamoxifen (TAM) is a commonly used medication to reduce the risk of developing breast cancer, but further research is needed to understand interactions between hormonal contraceptives (e.g., “the pill”) and TAM on the safety and efficacy of both medications. Since family planning is of major importance for premenopausal women, this gap in knowledge will be addressed through study in breast tissue and lab rats. Through these studies, we hope to understand if hormonal contraception is harmful to women in need of TAM, as well as different responses to two different contraceptives, which is expected to lead to clinical trials on this important issue.

Seema Khan, MD

Northwestern University Feinberg School of Medicine

News & Articles

3 Chicago Hospitals Team Up to Fight Breast Cancer in New Clinical Trial

Top Chicago Hospitals Join Forces in the Chicago Breast Cancer Research Consortium

Three Chicago Hospitals Collaborate on Breast Cancer Clinical Trial

Meet Our Other Scholars

Newly funded researchers pursuing high-risk, high-reward breast cancer studies in their first or second academic positions.

Dezheng Huo, PhD

Current

Senior Investigator

Dezheng Huo, PhD

Using Artificial Intelligence to Integrate Imaging and Genetic Markers for Personalized Breast Cancer Risk Prediction

Kay F. Macleod, PhD

Current

Senior Investigator

Kay F. Macleod, PhD

NIXing Breast Cancer

Amanda L. Marzo, PhD headshot v2

Current

Senior Investigator

Amanda L. Marzo, PhD

Reversing Resistance to Anti-Pd1 Therapy in Triple-Negative Breast Cancer

Why your gift matters

Every scholar funded is a future breakthrough made possible

Your gift helps researchers test bold ideas, generate critical data, and take the first steps toward the next major advancement in breast cancer treatment and care.Together, we can accelerate discoveries that save lives.

Contact Us

Email info@lynnsage.org
Contact Form (#6)